Research Article
Prognostic Value of Serum Albumin at Admission for Neurologic Outcome with Targeted Temperature Management after Cardiac Arrest
Table 2
Comparison of patients according to 6-month neurologic outcome.
| | Good neurologic outcome (n = 84) | Poor neurologic outcome (n = 171) | |
| Demographics | Male | 64 (76.2) | 116 (67.8) | 0.169 | Age, years | 48.3 ± 15.2 | 57.9 ± 16.5 | <0.001 |
| Comorbidities | CAD | 12 (14.3) | 19 (11.1) | 0.466 | CHF | 3 (3.6) | 5 (2.9) | 0.721 | Stroke | 0 (0.0) | 5 (2.9) | 0.175 | Hypertension | 16 (19.0) | 60 (35.1) | 0.008 | Diabetes mellitus | 5 (6.0) | 50 (29.2) | <0.001 | Renal disease | 0 (0.0) | 17 (9.9) | 0.001 | Liver disease | 0 (0.0) | 2 (1.2) | 0.449 | Malignancy | 1 (1.2) | 10 (5.8) | 0.074 |
| Resuscitation variables | Cardiac cause | 79 (94.0) | 96 (56.1) | <0.001 | Shockable rhythm | 68 (81.0) | 30 (17.5) | <0.001 | Witnessed | 72 (85.7) | 110 (64.7) | <0.001 | Bystander CPR | 52 (61.9) | 90 (52.9) | 0.176 | Anoxic time (min) | 23.6 ± 15.0 | 38.6 ± 20.3 | <0.001 |
| Post-ROSC N/Ex | PLR | 64 (76.2) | 31 (18.1) | <0.001 | Self-respiration | 73 (86.9) | 58 (33.9) | <0.001 | GCS motor, yes | 47 (56.0) | 13 (7.6) | <0.001 |
| Hemodynamic status | MAP | 99.2 ± 25.2 | 87.6 ± 26.9 | 0.001 | HR | 101.2 ± 25.7 | 104.3 ± 28.4 | 0.407 | Temperature | 35.8 ± 0.9 | 35.5 ± 1.4 | 0.060 | Hypoalbuminemia | 14 (16.7) | 95 (55.6) | <0.001 | Albumin (mg/dl) | 3.9 ± 0.4 | 3.3 ± 0.6 | <0.001 |
| Outcomes | Pneumonia | 26 (31.0) | 83 (48.5) | 0.008 | Septic shock | 4 (4.8) | 22 (12.9) | 0.049 | HD (days) | 7 (4–20) | 15 (9–23) | <0.001 |
|
|